Maya Dadiani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Maya Dadiani has a total of 346 co-authors. Here are the top co-authors by number of shared publications:
- Ruth Scherz-Shouval
Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel
24 shared publications - Ofra Golani
Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel
23 shared publications - Reinat Nevo
Weizmann Institute of Science
22 shared publications - Aviad Ben-Shmuel
Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel
21 shared publications - Coral Halperin
Department of Biomolecular Sciences, The Weizmann Institute of Science, Rehovot, Israel
21 shared publications - Dana Morzaev-Sulzbach
Chaim Sheba Medical Center, Institute of Oncology, Tel-Hashomer, Israel
21 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by Springer Nature in Nature
Epigenetic heterogeneity in breast tumours informs diagnosis and prognosis
Breast cancer, the most diagnosed cancer among women, is stratified by gene expression patterns into luminal and basal-like subtypes, and the latter is associated with worse prognosis1-3. Recent advances in single-cell technologies have underscored the presence of intratumour heterogeneity, which poses substantial challenges in cancer treatment and achieving long-term disease-free survival4-7. Here we extensively profile epigenetic heterogeneity in a cohort of treatment-naive human luminal tumours, which were obtained directly after surgical resection. By applying a single-cell epigenetic approach based on cytometry by time-of-flight, we identify a recurrent subpopulation of basal-like cells in luminal tumours with a conserved epigenetic signature across patients. These basal-like cells, also identified by deconvolution of whole-genome DNA methylation patterns, are characterized by high expression of aggressive oncogenic traits and downregulation of hormone receptor signalling. Direct comparison of single-cell proteomic and genomic profiling of monomethylation and trimethylation of histone 3 on lysine 4 revealed that these marks are key features associated with loss of luminal identity. Finally, we highlight the potential of concomitant single-molecule profiling of histone modifications on cell-free nucleosomes in blood as an epigenetic liquid biopsy approach for early diagnosis of breast cancer. Moreover, the epigenetic basal signature measured in blood is linked to prognosis, which enables the identification of patients at increased risk for disease relapse.
- 11 November 2026
- Published by Springer Nature in Nature
Open AccessEpigenetic heterogeneity in breast tumours informs diagnosis and prognosis
Breast cancer, the most diagnosed cancer among women, is stratified by gene expression patterns into luminal and basal-like subtypes, and the latter is associated with worse prognosis1-3. Recent advances in single-cell technologies have underscored the presence of intratumour heterogeneity, which poses substantial challenges in cancer treatment and achieving long-term disease-free survival4-7. Here we extensively profile epigenetic heterogeneity in a cohort of treatment-naive human luminal tumours, which were obtained directly after surgical resection. By applying a single-cell epigenetic approach based on cytometry by time-of-flight, we identify a recurrent subpopulation of basal-like cells in luminal tumours with a conserved epigenetic signature across patients. These basal-like cells, also identified by deconvolution of whole-genome DNA methylation patterns, are characterized by high expression of aggressive oncogenic traits and downregulation of hormone receptor signalling. Direct comparison of single-cell proteomic and genomic profiling of monomethylation and trimethylation of histone 3 on lysine 4 revealed that these marks are key features associated with loss of luminal identity. Finally, we highlight the potential of concomitant single-molecule profiling of histone modifications on cell-free nucleosomes in blood as an epigenetic liquid biopsy approach for early diagnosis of breast cancer. Moreover, the epigenetic basal signature measured in blood is linked to prognosis, which enables the identification of patients at increased risk for disease relapse.
- Open Access
- 5 May 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (9)
InSituPREP enables 3D single-cell mapping of interaction-associated gene programs in the breast cancer tumor microenvironment
Cell-cell interactions influence gene expression in the tumor microenvironment, yet despite advances in spatial transcriptomics that enable in situ expression profiling, current computational tools remain limited in quantitatively resolving single-cell and multicellular interaction effects across patient tissues. Here, we present InSituPREP (In Situ Proximity Expression Programs), a computational framework for quantifying how spatial context relates to transcriptional states in three-dimensional tissues at single-cell resolution. The framework quantifies proximity-associated gene programs across multiple analytical layers. We applied InSituPREP to Expansion Sequencing data from breast cancer biopsies of 10 patients, integrating newly generated and previously published datasets and profiling 299 cancer-related genes. This analysis revealed that a portion of within-cell type variability reflects proximity-associated transcriptional states, that proximity-dependent programs are reproducible across patients and measurement platforms, and that spatial RNA velocity links intercellular distance to future transcriptional trajectories. Linear modeling showed that gene expression in specific cell types varies with intercellular distance and the number of neighboring cells, while triplet configurations revealed additional interaction-associated programs. Moreover, simultaneous detection of bacterial signals and host mRNA enabled us to link bacterial proximity to distinct transcriptional responses. InSituPREP provides a framework for quantifying spatially associated gene expression and dissecting context-dependent transcriptional states at single-cell resolution.
- 5 May 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (9)
Open AccessInSituPREP enables 3D single-cell mapping of interaction-associated gene programs in the breast cancer tumor microenvironment
Cell-cell interactions influence gene expression in the tumor microenvironment, yet despite advances in spatial transcriptomics that enable in situ expression profiling, current computational tools remain limited in quantitatively resolving single-cell and multicellular interaction effects across patient tissues. Here, we present InSituPREP (In Situ Proximity Expression Programs), a computational framework for quantifying how spatial context relates to transcriptional states in three-dimensional tissues at single-cell resolution. The framework quantifies proximity-associated gene programs across multiple analytical layers. We applied InSituPREP to Expansion Sequencing data from breast cancer biopsies of 10 patients, integrating newly generated and previously published datasets and profiling 299 cancer-related genes. This analysis revealed that a portion of within-cell type variability reflects proximity-associated transcriptional states, that proximity-dependent programs are reproducible across patients and measurement platforms, and that spatial RNA velocity links intercellular distance to future transcriptional trajectories. Linear modeling showed that gene expression in specific cell types varies with intercellular distance and the number of neighboring cells, while triplet configurations revealed additional interaction-associated programs. Moreover, simultaneous detection of bacterial signals and host mRNA enabled us to link bacterial proximity to distinct transcriptional responses. InSituPREP provides a framework for quantifying spatially associated gene expression and dissecting context-dependent transcriptional states at single-cell resolution.
- Top Cited Papers
- 15 July 2025
- Published by Springer Nature in Nature Medicine
- Vol. 31 (9) , 3191-3203
Deep phenotyping of health–disease continuum in the Human Phenotype Project
The Human Phenotype Project (HPP) is a large-scale deep-phenotype prospective cohort. To date, approximately 28,000 participants have enrolled, with more than 13,000 completing their initial visit. The project is aimed at identifying novel molecular signatures with diagnostic, prognostic and therapeutic value, and at developing artificial intelligence (AI)-based predictive models for disease onset and progression. The HPP includes longitudinal profiling encompassing medical history, lifestyle and nutrition, anthropometrics, blood tests, continuous glucose and sleep monitoring, imaging and multi-omics data, including genetics, transcriptomics, microbiome (gut, vaginal and oral), metabolomics and immune profiling. Analysis of these data highlights the variation of phenotypes with age and ethnicity and unravels molecular signatures of disease by comparison with matched healthy controls. Leveraging extensive dietary and lifestyle data, we identify associations between lifestyle factors and health outcomes. Finally, we present a multi-modal foundation AI model, trained using self-supervised learning on diet and continuous-glucose-monitoring data, that outperforms existing methods in predicting disease onset. This framework can be extended to integrate other modalities and act as a personalized digital twin. In summary, we present a deeply phenotyped cohort that serves as a platform for advancing biomarker discovery, enabling the development of multi-modal AI models and personalized medicine approaches.
- 15 July 2025
- Published by Springer Nature in Nature Medicine
- Vol. 31 (9) , 3191-3203
Top Cited PapersDeep phenotyping of health–disease continuum in the Human Phenotype Project
The Human Phenotype Project (HPP) is a large-scale deep-phenotype prospective cohort. To date, approximately 28,000 participants have enrolled, with more than 13,000 completing their initial visit. The project is aimed at identifying novel molecular signatures with diagnostic, prognostic and therapeutic value, and at developing artificial intelligence (AI)-based predictive models for disease onset and progression. The HPP includes longitudinal profiling encompassing medical history, lifestyle and nutrition, anthropometrics, blood tests, continuous glucose and sleep monitoring, imaging and multi-omics data, including genetics, transcriptomics, microbiome (gut, vaginal and oral), metabolomics and immune profiling. Analysis of these data highlights the variation of phenotypes with age and ethnicity and unravels molecular signatures of disease by comparison with matched healthy controls. Leveraging extensive dietary and lifestyle data, we identify associations between lifestyle factors and health outcomes. Finally, we present a multi-modal foundation AI model, trained using self-supervised learning on diet and continuous-glucose-monitoring data, that outperforms existing methods in predicting disease onset. This framework can be extended to integrate other modalities and act as a personalized digital twin. In summary, we present a deeply phenotyped cohort that serves as a platform for advancing biomarker discovery, enabling the development of multi-modal AI models and personalized medicine approaches.
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Table 2 shows RNA sequencing of mouse NK cells
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Table 2 shows RNA sequencing of mouse NK cells
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 2 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is from a 2nd of 3 biologically independent experiments
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video 2 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 2 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is from a 2nd of 3 biologically independent experiments
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Table 3 shows IHC and MxIF staining data from 72 TNBC patient TMA
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Table 3 shows IHC and MxIF staining data from 72 TNBC patient TMA
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 3 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is a close-up ROI of Supplementary Video 2
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 3 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is a close-up ROI of Supplementary Video 2
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Data from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Cancer-associated fibroblasts (CAF) are abundant components of the breast tumor microenvironment and major contributors to immune-modulation. CAFs regulate the activity of many immune cells including T cells, macrophages, and dendritic cells; however, little is known about their interaction with NK cells, which constitute an important arm of antitumor immunity. Using mouse models of breast cancer and ex vivo cocultures, we find that CAFs inhibit NK cell cytotoxicity toward cancer cells. We unravel the mechanism by which suppression occurs, which is through ligand–receptor engagement between NK cells and CAFs, leading to CAF cytolysis and downregulation of activating receptor expression on NK cells, promoting cancer cell escape from NK cell surveillance. In patients with triple-negative breast cancer, we find enrichment of NK cells in CAF-rich regions and upregulation of NK-binding ligands on CAFs, which correlates with poor disease outcomes. These results reveal a CAF-mediated immunosuppressive decoy mechanism with implications for the treatment of carcinomas.Significance:Little is known about the influence of CAFs on NK cells in the context of carcinomas. Here, we mechanistically unravel a pathway of CAF-mediated suppression of NK cells in breast cancer, opening possible avenues for new biomarkers and strategies for immune-based therapies.See related commentary by Sherman, p. 1096
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Cancer-associated fibroblasts (CAF) are abundant components of the breast tumor microenvironment and major contributors to immune-modulation. CAFs regulate the activity of many immune cells including T cells, macrophages, and dendritic cells; however, little is known about their interaction with NK cells, which constitute an important arm of antitumor immunity. Using mouse models of breast cancer and ex vivo cocultures, we find that CAFs inhibit NK cell cytotoxicity toward cancer cells. We unravel the mechanism by which suppression occurs, which is through ligand–receptor engagement between NK cells and CAFs, leading to CAF cytolysis and downregulation of activating receptor expression on NK cells, promoting cancer cell escape from NK cell surveillance. In patients with triple-negative breast cancer, we find enrichment of NK cells in CAF-rich regions and upregulation of NK-binding ligands on CAFs, which correlates with poor disease outcomes. These results reveal a CAF-mediated immunosuppressive decoy mechanism with implications for the treatment of carcinomas.Significance:Little is known about the influence of CAFs on NK cells in the context of carcinomas. Here, we mechanistically unravel a pathway of CAF-mediated suppression of NK cells in breast cancer, opening possible avenues for new biomarkers and strategies for immune-based therapies.See related commentary by Sherman, p. 1096
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Figure 3 shows upregulation of ligands for NK cell receptors on CAFs
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Figure 3 shows upregulation of ligands for NK cell receptors on CAFs
- Open Access
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Video 1 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 1 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is from 1 of 3 biologically independent experiments
- 3 June 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Video 1 from Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer
Supplementary Video 1 shows 4T1-GFP cells (green) and cytopainter red-labeled pCAFs (magenta) were seeded as described in Methods. NK cells from spleens of BALB/C mice were activated overnight with IL-2+IL-15 and were introduced to wells with 4T1+pCAFs and immediately imaged for 16 hours. This is video is from 1 of 3 biologically independent experiments